IPSC - Wall Street Estimates - Century Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.9093

0.453 %

$ 77.3 M

Market Cap

-0.5

P/E

Price Target Average

1251.12%

Revenue Forecast Estimate

309.17%

EBIT Estimate

30.24%

Net Income Estimate

4.77%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Century Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for IPSC of $12.3 , with forecasts ranging from a low of $5 to a high of $25 .

IPSC Lowest Price Target Wall Street Target

5 USD 449.87%

IPSC Average Price Target Wall Street Target

12.3 USD 1251.12%

IPSC Highest Price Target Wall Street Target

25 USD 2649.37%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free